T-cell acute lymphoblastic leukemia
Clinical trials for T-cell acute lymphoblastic leukemia explained in plain language.
Never miss a new study
Get alerted when new T-cell acute lymphoblastic leukemia trials appear
Sign up with your email to follow new studies for T-cell acute lymphoblastic leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New universal CAR t therapy targets tough blood cancers
Disease control Not yet recruitingThis early-stage trial tests a new type of immune cell therapy (called universal CAR T cells) for people with certain blood cancers, including T-cell leukemia and lymphoma. The therapy targets a protein called CD7 found on cancer cells. The study will check if the treatment is sa…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase 1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Engineered immune cells take aim at stubborn blood cancers
Disease control Not yet recruitingThis study tests a new type of immunotherapy called CAR-T cells that are designed to recognize and attack cancer cells carrying a protein called CD7. It includes people with several blood cancers, such as T-cell acute lymphoblastic leukemia and acute myeloid leukemia. The goal is…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
A pill after transplant: new hope to stop t-cell cancer relapse
Disease control Not yet recruitingThis trial tests whether taking chidamide, an oral drug, after a stem cell transplant can lower the chance of the cancer coming back in people with high-risk T-cell acute lymphoblastic leukemia or lymphoma. Participants are randomly assigned to receive chidamide for up to 24 mont…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase 3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Could an antibody boost chemo for tough blood cancers?
Disease control Not yet recruitingThis large clinical trial is testing whether adding the drug daratumumab to standard chemotherapy helps children and young adults with newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL). Daratumumab is an antibody that targets a pr…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase 2/3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat T-Cell cancers
Disease control Not yet recruitingThis study tests a new treatment called nano CD5-CAR T cells for people with relapsed or refractory T-cell acute lymphoblastic leukemia or T-cell lymphoma. The therapy uses a patient's own immune cells, modified in a lab to recognize and attack cancer cells that carry the CD5 pro…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase 1/2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC